Surface Oncology is a biotechnology business based in the US. Surface Oncology shares (SURF) are listed on the NASDAQ and all prices are listed in US Dollars. Surface Oncology employs 35 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Surface Oncology stock
How to buy Surface Oncology stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SURF. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Surface Oncology stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Surface Oncology stock price (NASDAQ: SURF)
Use our graph to track the performance of SURF stocks over time.Surface Oncology shares at a glance
Latest market close | $1.07 |
---|---|
52-week range | $0.83 - $1.12 |
50-day moving average | $0.95 |
200-day moving average | $0.82 |
Wall St. target price | $2.38 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.66 |
Is it a good time to buy Surface Oncology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Surface Oncology price performance over time
Historical closes compared with the close of $1.07 from 2023-09-12
1 week (2024-07-16) | N/A |
---|---|
1 month (2024-06-23) | N/A |
3 months (2024-04-23) | N/A |
6 months (2024-01-23) | N/A |
1 year (2023-07-27) | 15.05% |
---|---|
2 years (2022-07-27) | -38.86% |
3 years (2021-07-27) | 5.84 |
5 years (2019-07-26) | 2.14 |
Surface Oncology financials
Gross profit TTM | $-37,003,000 |
---|---|
Return on assets TTM | -41.42% |
Return on equity TTM | -105.78% |
Profit margin | 0% |
Book value | $0.81 |
Market Capitalization | $65.7 million |
TTM: trailing 12 months
Surface Oncology share dividends
We're not expecting Surface Oncology to pay a dividend over the next 12 months.
Surface Oncology share price volatility
Over the last 12 months, Surface Oncology's shares have ranged in value from as little as $0.827 up to $1.12. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Surface Oncology's is 1.7527. This would suggest that Surface Oncology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Surface Oncology overview
Surface Oncology, Inc. , a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 which is in phase II clinical trial targeting interleukin 27; GSK4381562, an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 that is in phase 1/2 clinical trials targeting the chemokine receptor CCR8. Surface Oncology, Inc. has a license agreement with GlaxoSmithKline Intellectual Property (No. 4) Limited and Vaccinex, Inc. to develop, manufacture, and commercialize antibodies, which targets SRF114.
Frequently asked questions
What percentage of Surface Oncology is owned by insiders or institutions?Currently 7.277% of Surface Oncology shares are held by insiders and 46.033% by institutions. How many people work for Surface Oncology?
Latest data suggests 35 work at Surface Oncology. When does the fiscal year end for Surface Oncology?
Surface Oncology's fiscal year ends in December. Where is Surface Oncology based?
Surface Oncology's address is: 50 Hampshire Street, Cambridge, MA, United States, 02139 What is Surface Oncology's ISIN number?
Surface Oncology's international securities identification number is: US86877M2098 What is Surface Oncology's CUSIP number?
Surface Oncology's Committee on Uniform Securities Identification Procedures number is: 86877M209
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 top semiconductor stocks to buy in 2024
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question